Innate and acquired immune system in patients developing interferon-alpha-related autoimmune thyroiditis: a...

Area of Science:

• Immunology
• Endocrinology
• Virology

Background:

• Interferon (IFN)-alpha therapy for Hepatitis C Virus (HCV) can induce autoimmune thyroiditis (IFN-AT).
• The specific cytokine profiles associated with the development and progression of IFN-AT remain incompletely understood.

Purpose of the Study:

• To investigate the correlation between sequential changes in peripheral lymphocyte cytokine patterns and the development of IFN-alpha-related autoimmune thyroiditis (IFN-AT).
• To differentiate cytokine responses in patients who develop euthyroid IFN-AT versus those who develop thyroid dysfunction.

Main Methods:

• Prospective study of 18 HCV-positive patients with IFN-AT (8 euthyroid, 10 with dysfunction) and 20 controls.
• Intracellular IFN-gamma and IL-4 expression in peripheral lymphocytes analyzed via multicolor flow cytometry after in vitro stimulation.
• Analysis conducted at the appearance of thyroid disease and at a 6-month follow-up.

Main Results:

• Both euthyroid and dysfunctional IFN-AT patients showed increased IFN-gamma at disease onset.
• Euthyroid IFN-AT patients additionally showed increased IL-4, maintained at 6 months.
• Thyroid-dysfunctional IFN-AT patients exhibited increased IFN-gamma and decreased IL-4 at 6 months.

Conclusions:

• A Type 2 immune response is activated early and specifically in euthyroid IFN-AT patients.
• A predominant Type 1 immune response, potentially earlier in the innate immune system, is observed in patients developing thyroid dysfunction.